Pituitary Tumors-Acromegaly (posters)

FRI-489

Prevalence of Acromegaly in a Large US Managed Care Population
Tanya Burton, Elisabeth LeNestour, Maureen P Neary and William H Ludlam

FRI-490

Historical Response Rates of Somatostatin Analogs in the Treatment of Acromegaly
Michael Howard Shanik, Paul Cao and William H Ludlam

FRI-491

Factors Associated with Quality of Life in Japanese Patients with Acromegaly
Kenichi Yoshida, Hidenori Fukuoka, Ryusaku Matsumoto, Hironori Bando, Kentaro Suda, Hitoshi Nishizawa, Genzo Iguchi, Wataru Ogawa, Susan M. Webb and Yutaka Takahashi

FRI-492

FRI-496

Acrodat: Identification of Disease Activity in Patients with Acromegaly
Aart J. van der Lely, Andreas M. Pleil, Xavier Badia, Thierry Brue, Michael Buchfelder, Pia Burman, Ezio Ghigo, Roy Gomez, Jens Otto Lunde Jørgensen, Anton Luger, Joli van der Lans, Susan M. Webb and Christian J Strasburger

FRI-497

FRI-498

Prognostic Significance of Markers of Histological Atypia in Acromegaly: An Emory University Extended Cohort Series
Jeremy Richard Anthony, Daniel Brat, Octavian C Ioachimescu, Nelson M Oyesiku and Adriana Gabriela Ioachimescu

FRI-499

Use of Combination Medical Therapy Is Common in Acromegaly
Christian J Strasburger, Judith Hey-Hadavi, Ann-Charlotte Akerblad, Anders F. Mattsson, Maria Koltowska-Haggstrom, Patrick Wilton and Beverly M.K. Biller

FRI-500

Sagit©: A Novel Clinician-Reported Outcome Tool for Managing Acromegaly in Clinical Practice
Andrea Giustina, John S Bevan, Marcello D Bronstein, Felipe F Casanueva, Philippe Chanson, Stephan Petersenn, Xuan-Mai Truong Thanh, Christine Massien, Carla Dias-Barbosa, Isabelle Guillemin, Benoit Arnould and Shlomo Melmed

FRI-501

Do T2-Hypointense GH-Secreting Pituitary Adenomas Behave Differently Under Somatostatin Analogues As Primary Therapy in Acromegaly?
Iulia Potorac, Patrick Petrossians, Adrian F Daly, Liliya Rostomyan, Mona Sahnoun-Fathallah, Frederic Castinetti, Thierry Brue, Orsalia Alexopoulou, Dominique Maiter, Franck Schillo, France Devuyst, Bernard Corvilain, Ammar Muhammad, Sebastian J.C.M.M. Neggers, Fahrettin Kelestimur, Christof Schofl, Flavius Zoicas, Michael Buchfelder, Elena Nazzari, Laura Roffredo, Diego Ferone, Florina Luca, Bernard Goichot, Gerald Raverot, Veronique Lapras, Sophie Kalfon, Susan M. Webb, Analia Emilce Ramos, Frederic Illouz, Vincent Rohmer, Patrice Rodien, Rogelio Garcia Centeno, Vaclav Hana, Farida Nasybullina, Gulnar Vagapova, Jean-François Bonneville and Albert Beckers

FRI-502

Ki-67 Is Not a Predictor of Acromegaly Response to Pegvisomant
Antonio Bianchi, Sabrina Chiloiro, Antonella Giampietro, Linda Tartaglione, Marilda Mormando, Francesca Lugli, Serena Piacentini, Francesco Doglietto, Carmelo Anile, Giulio Maira, Libero Lauriola, Guido Rindi, Alfredo Pontecorvi and Laura De Marinis

FRI-503

No Medication Means No Chronic Illness to Patients with Acromegaly: Negative Medication Beliefs Are Related to More Negative Illness Perceptions
Cornelie D. Andela, Nienke R. Biermasz, Adrian A Kaptein, Alberto M. Pereira and Jitske Tiemensma